Contact Us
-
Diet Specialists
Categories
-
Recent Posts
- How Anant Ambani struggled from weight gain due to steroids from asthma treatment – The Times of India
- Usha Chilukuri says hubby Vance adapted her vegetarian diet and learned how to cook Indian food for his mom-in law – The Tribune India
- Instead of crisps, kids could eat snacks from the sea: the forager chef looking to revolutionise Chiles diet – The Guardian
- Banana to mushroom: How a plant-based diet can help you hair and overall well-being – The Times of India
- Is it possible to lose weight in just a few weeks through water fasting? All about the viral weight loss – The Times of India
Archives
Search Weight Loss Topics: |
Category Archives: Testosterone
What is testosterone replacement therapy, and do you need it – KTAR.com
Posted: March 30, 2020 at 9:46 pm
Talk to anyone whose been around for a few decades, and youll usually hear that life gets sweeter with age. Even with the inevitable slowdown that starts in your 30s, your best years can still be ahead.
Perhaps youve noticed that slowdown: If you become fatigued more easily than you used to, your mind isnt as sharp, or your libido is on the decline, it could be because of low testosterone.
As you grow, your brain periodically produces signal hormones responsible for stimulating testosterone production, according to Vital4Men. Testosterone is the main hormone responsible for the growth and development of male sex organs, muscle mass, and bone density. It also gives you energy and affects your mood.
When testosterone reaches an acceptable range, brain signals slow down, which allows your testosterone to lower. However, that decrease could lead to testicular problems at this stage. This low level of testosterone production is called hypogonadism.
Signs you may have low testosterone
The symptoms of low testosterone or hypogonadism include the following:
You may not think that you have low testosterone if you ignore symptoms or simply attribute them to aging. Unfortunately, hoping these issues will go away on their own wont work and, in fact, you may notice they just get worse.
Your testosterone levels will likely continue to decline over time and the severity of your symptoms will most likely continue to increase, Vital4Men says.
However, if you pay attention, the good news is that low testosterone is treatable, so you can feel like yourself again and look forward to the years ahead.
One of the best treatments is testosterone replacement therapy.
What is testosterone replacement therapy?
Testosterone replacement therapy can improve the symptoms of low testosterone. Doctors may prescribe testosterone through injections, gels, patches, surgically implanted pellets, or oral options to improve hormone levels.
The treatment process is simple. For example, when you visit Vital4men, the medical professionals will perform a blood test to determine if you are an eligible candidate for testosterone replacement therapy, and youll receive your results within a few days.
If your testosterone levels fall outside the normal range, you may be a candidate for treatment. Your doctor will go over potential side effects to determine if testosterone replacement therapy is the right option.
At the viTal4men clinic, we treat low testosterone levels with testosterone replacement therapy to get you back to your optimum level, the company says. We are a complete mens wellness center.
The clinic will support you through the entire process. The best part, though, is the results. While your outcome will be individual, there are many potential benefits to testosterone replacement therapy:
If youre experiencing any of the symptoms of low testosterone, dont give up hope. Visit Vital4Men for more information and to schedule a free testosterone level test.
Excerpt from:
What is testosterone replacement therapy, and do you need it - KTAR.com
Posted in Testosterone
Comments Off on What is testosterone replacement therapy, and do you need it – KTAR.com
Advanced Age Management Offer Testosterone Replacement Therapy – The News Front
Posted: March 27, 2020 at 3:56 am
Advanced Age Management offers Testosterone Replacement Therapy. This mens clinic is located near Cleveland, OH, and it gives men the perfect solution if they are feeling sluggish, low energy, gaining weight, or they have a decreased sex drive. Advanced Age Management says if youre over the age of 35, you could have low testosterone, and this is normal as you get older, but you will start to notice issues more and more as you age.
This mens clinic in Cleveland, OH, says it is due to a condition called Hypergonadism, yet, they want to reassure individuals who may be concerned and worried that their testosterone production level is low, that is why they are now offering testosterone replacement therapy in their clinic. If you are suffering from one of the issues mentioned above, definitely consider scheduling an appointment with your doctor and get your testosterone levels checked. Contact Advanced Age Management, and they will advise you on your next step and get you in for a free testosterone assessment.
At Advanced Age Management, their goal is to help men build up their testosterone levels by testing testosterone levels and creating a treatment plan to get the testosterone levels back to an appropriate level so that each individual does not have to suffer anymore and can carry on with their life. This is all done through the testosterone replacement therapy at their mens clinic.
It would be best if you got in touch with Dr. John Kocka at Advanced Age Management, a low testosterone expert who carries out a series of assessments and testosterone replacement therapy for men and women in and around Cleveland Ohio. According to Advanced Age Management, the cost of the testosterone replacement therapy varies from each patient to the next, as each person will require a different treatment plan. You can, however, schedule a free consultation and also review your financial information with Dr. John Kocka once you get in touch.
Advanced Age Management emphasizes that the therapy offered to men is only for those with testosterone deficiencies, which is why this mens clinic is the best to consult with if you have found out that you have low testosterone. If needed, Dr.Kocka can offer you a same-day consultation.
If you have been given the go-ahead for testosterone replacement therapy, Advanced Age Management assures you that there are many benefits of testosterone treatment. There is evidence to suggest the therapy can improve your cardiovascular health by removing cholesterol from your arteries, a common issue that many men suffer with as they get older.
The mens clinic in Cleveland, OH, assists men for other hormone treatments as well, such as DHEA, cortisol, thyroid, natural growth hormone, insulin, and more.
Contact Advanced Age Management today at (330) 439-6591 and schedule your free consultation with one of their low testosterone doctors. This mens clinic is offering you the chance to increase your testosterone levels and, in turn, improve your health and overall well-being. At Advanced Age Management, the doctors use injection therapy for men who need more testosterone production. You can read more about low testosterone and the testosterone replacement therapy on their website at https://www.lowtohio.com.
Source:https://thenewsfront.com/advanced-age-management-offer-testosterone-replacement-therapy/
See more here:
Advanced Age Management Offer Testosterone Replacement Therapy - The News Front
Posted in Testosterone
Comments Off on Advanced Age Management Offer Testosterone Replacement Therapy – The News Front
Testosterone Replacement Therapy Market All Set to Achieve Higher Revenues Global Forecast 2027 | Endo Pharmaceuticals, Inc., Eli Lilly and Company,…
Posted: March 27, 2020 at 3:56 am
Coherent Market Insights Analytics recently introduced Global Testosterone Replacement Therapy Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2027. Testosterone Replacement Therapy Market explores effective study on varied sections of Industry like opportunities, size, growth, technology, demand and trend of high leading players. It also provides market key statistics on the status of manufacturers, a valuable source of guidance, direction for companies and individuals interested in the industry.
Few Notable Key Players Names In The Market For Testosterone Replacement Therapy: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.
Request a Sample Copy + All Related Graphs & Charts: https://www.coherentmarketinsights.com/insight/request-sample/2024
Opportunities
This research is categorized differently considering the various aspects of this market. It also evaluates the current situation and the future of the market by using the forecast horizon. The forecast is analyzed based on the volume and revenue of this market. The tools used for analyzing the Global Testosterone Replacement Therapy Market research report include SWOT analysis.
The regional analysis of Global Testosterone Replacement Therapy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Whereas, owing to rising no. of research activities in countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate the forecast period 2020-2027.
Highlights of the report:
o A complete backdrop analysis, which includes an assessment of the parent market
o Important changes in market dynamics
o Market segmentation up to the second or third level
o Historical, current, and projected size of the market from the standpoint of both value and volume
o Reporting and evaluation of recent industry developments
o Market shares and strategies of key players
o Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
For Early Buyers | Get Up to 20% Discount on This Premium Report: https://www.coherentmarketinsights.com/insight/buy-now/2024
Strategic Points Covered in Table of Content of Global Testosterone Replacement Therapy Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Testosterone Replacement Therapy market
Chapter 2: Exclusive Summary the basic information of the Testosterone Replacement Therapy Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Testosterone Replacement Therapy
Chapter 4: Presenting the Testosterone Replacement Therapy Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region 2013-2018
Chapter 6: Evaluating the leading manufacturers of the Testosterone Replacement Therapy market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source, finally, Testosterone Replacement Therapy Market is a valuable source of guidance for individuals and companies.
Key questions answered
1. Who are the Leading key players and what are their Key Business plans in the Global Testosterone Replacement Therapy market?
2. What are the key concerns of the five forces analysis of the Global Testosterone Replacement Therapy market?
3. What are different prospects and threats faced by the dealers in the Global Testosterone Replacement Therapy market?
4. What are the strengths and weaknesses of the key vendors?
Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.
Thanks for reading this article, we can also provide customized report as per companys specific needs. You can also get separate chapter wise or region wise report versions including North America, Europe or Asia.
Download the PDF Brochure + All Related Graphs & Charts: https://www.coherentmarketinsights.com/insight/request-pdf/2024
About Author:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:Coherent Market Insights 1001 4th Ave,#3200 Seattle, WA 98154,U.SPhone: US +12067016702 / UK +4402081334027Email: [emailprotected]
Follow this link:
Testosterone Replacement Therapy Market All Set to Achieve Higher Revenues Global Forecast 2027 | Endo Pharmaceuticals, Inc., Eli Lilly and Company,...
Posted in Testosterone
Comments Off on Testosterone Replacement Therapy Market All Set to Achieve Higher Revenues Global Forecast 2027 | Endo Pharmaceuticals, Inc., Eli Lilly and Company,…
Global Hormone Replacement Therapy (HRT) Tablets Market Trends, Research, Analysis & Forecast 2026 Major Growth By Novo Nordisk A/S, Sanofi,…
Posted: March 27, 2020 at 3:56 am
The hormone replacement therapy (HRT) tablets market study consists of the key factors of strategic trends of the market including R&D, new product launching, agreements, collaborations, partnerships, joint ventures, and local size of the leading competition performing within the market on a worldwide and regional scale. This industry analysis report consists of the exactly studied and weighed statistics of the important thing enterprise players and their scope within the market via the method of numerous analytical gears. The hormone replacement therapy (HRT) tablets market report will surely offer strategic and tactical support to clients for making well-informed business decisions.
Get Sample Copy Of This Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hormone-replacement-therapy-hrt-tablets-market
Few of the major competitors currently working in the global hormone replacement therapy (HRT) tablets market areALLERGAN, Novo Nordisk A/S, Sanofi, Abbott, TherapeuticsMD, Inc., Mithra Pharmaceuticals among others.
Key Development in the Market:
Competitive Analysis
Global hormone replacement therapy (HRT) tablets market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hormone replacement therapy (HRT) tablets market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Table of Contents
1. Introduction2. Market Segmentation3. Market Overview4. Executive Summary5. Premium Insights6. Global, By Component7. Product Type8. Delivery9. Industry Type10. Geography
Get Full Table Of content @https://www.databridgemarketresearch.com/toc/?dbmr=global-hormone-replacement-therapy-hrt-tablets-market
Segmentation: Global Hormone Replacement Therapy (HRT) Tablets Market
By Type of Disease
(Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Others),
Product
(Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, Others),
End User
(Hospitals, Clinics, Ambulatory Surgery Centers, Others),
Distribution Channel
(Direct, Retail),
Geography
(North America, Europe, Asia-Pacific, South America, Middle East and Africa)
By Type of Disease
By Treatment Type
By End-User
By Distribution Channel
By Geography
Inquiry For Customize Report With Discount at :https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hormone-replacement-therapy-hrt-tablets-market
AboutData Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:Data Bridge Market ResearchTel: +1-888-387-2818Email:Corporatesales@databridgemarketresearch.com
View original post here:
Global Hormone Replacement Therapy (HRT) Tablets Market Trends, Research, Analysis & Forecast 2026 Major Growth By Novo Nordisk A/S, Sanofi,...
Posted in Testosterone
Comments Off on Global Hormone Replacement Therapy (HRT) Tablets Market Trends, Research, Analysis & Forecast 2026 Major Growth By Novo Nordisk A/S, Sanofi,…
Testosterone Replacement Therapy Market: Rise in Geriatric Population with High Risk of Testosterone Deficiency Boost Market Growth – BioSpace
Posted: March 26, 2020 at 4:44 am
Transparency Market Research (TMR)has published a new report titled, Testosterone Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027.According to the report, the globalTestosterone Replacement Therapy marketwas valued atUS$ 1,613.7 Mnin2018and is projected to expand at a CAGR of4.4%from2019to2027.
Overview
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1097
Growing Awareness about Testosterone Replacement Therapy to Drive Market
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1097
North America to Dominate Global Market
Request for Discount on this Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1097
Competitive Landscape
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
ContactTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/
Posted in Testosterone
Comments Off on Testosterone Replacement Therapy Market: Rise in Geriatric Population with High Risk of Testosterone Deficiency Boost Market Growth – BioSpace
ACR Recommendations for Managing Reproductive Health in Rheumatic and Musculoskeletal Diseases – Rheumatology Advisor
Posted: March 26, 2020 at 4:44 am
Based on emerging evidence and expert consensus, a panel assembled by the American College of Rheumatology (ACR) released recommendations for the management of reproductive health in patients with rheumatic and musculoskeletal diseases (RMD). This report was published in Arthritis & Rheumatology.
Investigators performed a systematic review of studies relating to contraception, assisted reproductive technologies, fertility preservation, menopausal hormone therapy, pregnancy and lactation, and medication use in patients with RMD. They developed recommendations using Grading of Recommendations Assessment, Development, and Evaluation methodology to rate evidence quality.
Recommendations for Contraception
The ACR strongly recommends the use of effective contraceptives, including hormonal contraceptives and intrauterine devices (IUDs), over no contraception in reproductive-age women with RMD without systemic lupus erythematosus (SLE) or antiphospholipid antibodies (aPLs). Long-acting reversible contraceptives such as IUDs or subdermal progestin implants are encouraged as first-line contraceptive methods because of their real-world effectiveness. The use of emergency contraception should be discussed with all patients because the risk for unplanned pregnancy in RMD outweighs the risk related to emergency contraception.
Patients With SLE
In patients with SLE with low or stable disease activity and who are not aPL-positive, the panel recommends the use of effective contraceptives over no contraception and encourages the use of highly effective IUDs or subdermal progestin implants as first-line contraceptive methods. However, the ACR recommends against the use of the transdermal estrogen-progestin patch as it results in greater estrogen exposure compared with oral or transvaginal methods, which potentially increase risk for flare or thrombosis.
In patients with SLE with moderate or severe disease activity, progestin-only or IUD contraception is recommended over combined estrogen-progestin contraceptive methods, as the latter has not been studied in this patient population.
aPL-Positive Patients
In aPL-positive women, the panel strongly recommends IUDs (levonorgestrel or copper) or the progestin-only pill and recommends against combined estrogen-progestin contraception because estrogen increases the risk for thromboembolism.
Other RMD Situations
In women with RMD who are receiving immune-suppressive therapy, copper or progestin IUDs are recommended as the most effective contraceptive option.
In women at risk for osteoporosis from glucocorticoid use or underlying disease, the ACR recommends against using depot medroxyprogesterone acetate (DMPA) injections as long-term contraception because DMPA is associated with declines in bone mineral density and fracture risk.
In women with RMD taking mycophenolate mofetil/mycophenolic acid, an IUD alone or 2 other contraceptive methods used together are suggested, as mycophenolate mofetil may reduce estrogen and progesterone levels and hence reduce the efficacy of oral contraceptives.
Recommendations for Assisted Reproductive Technology
The ACR strongly recommends women with uncomplicated RMD (stable/quiescent disease activity and without aPLs) who are receiving pregnancy-compatible medications proceed with assisted reproductive technology. However, rheumatologists should discuss with their patients the risks associated with assisted reproductive technology, especially lupus flare and thrombosis.
Patients With SLE
In patients with RMD who experience moderate to severe disease activity, assisted reproductive technology procedures should be deferred, as RMD disease activity may increase pregnancy-associated risks.
In women with SLE undergoing assisted reproductive technology procedures, the panel recommends against an empiric dosage increase of prednisone and recommends monitoring the patient carefully and treating a flare if it occurs.
aPL-Positive Patients
The ARC recommends assisted reproductive technologies with anticoagulation therapy in patients with RMD and stable/quiescent disease activity and who have asymptomatic positive aPLs, obstetric antiphospholipid syndrome, or treated thrombotic antiphospholipid syndrome.
Use of prophylactic anticoagulation therapy with heparin or low-molecular-weight heparin are strongly suggested for women with RMD undergoing assisted reproductive technology procedures who report asymptomatic positive aPLs or obstetric or treated thrombotic antiphospholipid syndrome.
Embryo and Oocyte Cryopreservation
Continuation of necessary immunosuppressive and/or biologic therapies (other than cyclophosphamide) are strongly encouraged in patients with stable disease activity who undergo ovarian stimulation for the purpose of oocyte retrieval or embryo cryopreservation.
Recommendations for Fertility Preservation
The ACR recommends monthly gonadotropin-releasing hormone agonist co-therapy to prevent primary ovarian insufficiency in premenopausal women with RMD who receive a monthly intravenous cyclophosphamide dose. However, men with RMD who receive cyclophosphamide should not receive testosterone co-therapy, as it does not help preserve fertility in men. Sperm cryopreservation is a strongly suggested practice for men before being treated with cyclophosphamide.
Recommendations for Menopause and Hormone Replacement Therapy
Hormone replacement therapy is strongly suggested in postmenopausal women with RMD without SLE or positive aPLs. In patients with SLE without positive aPLs, hormone replacement therapy is recommended conditionally because a small increase in risk for mild to moderate lupus flares is associated with oral hormone replacement therapy.
Hormone replacement therapy is not recommended in women with asymptomatic aPLs, or obstetric or thrombotic antiphospholipid syndrome. Furthermore, patients receiving anticoagulation treatment for antiphospholipid syndrome even patients who are negative for aPL should not use hormone replacement therapy.
In patients with a history of positive aPLs but who currently test negative for aPL and have no history of clinical antiphospholipid syndrome, hormone replacement therapy may be considered if desired.
Recommendations for Pregnancy
The ACR strongly suggests counseling women with RMD who are considering pregnancy, in which improved maternal and fetal outcomes have been associated with entering pregnancy with quiescent or low disease activity. Maintaining concurrent care with obstetricians-gynecologists, neonatologists, and other appropriate specialists is recommended as good practice.
Women with RMDs planning pregnancy should switch to pregnancy-compatible medications with enough time to assess efficacy and tolerability of the new medication.
For women with RMD who are currently pregnant and whose active disease requires continuous medication, pregnancy-compatible steroid-sparing treatment is strongly recommended, as high-dose glucocorticoids can potentially cause maternal or fetal harm.
Patients With SLE
Women with SLE or similar disorders (Sjgren syndrome, systemic sclerosis, rheumatoid arthritis) should be tested for anti-Sjgren syndrome-related antigen A (RO/SSA) and anti-Sjgren syndrome-related antigen B (La/SSB) antibodies in early pregnancy. However, because of the antibodies relative persistence, repeat testing during pregnancy is not needed.
In pregnant patients with active scleroderma renal crisis, the ACR strongly recommends the use of angiotensin-converting enzyme inhibitor or angiotensin receptor blockade therapy because the risk for maternal or fetal death outweighs the risk associated with these medications.
The ACR strongly suggests that pregnant women with SLE be closely monitored with clinical history, examination, and laboratory tests at least once per trimester as disease activity can affect pregnancy outcomes. If possible, all women with SLE should take hydroxychloroquine during pregnancy. Pregnant patients with SLE are also recommended to begin a daily low-dose aspirin (81 mg or 100 mg) regimen during their first trimester.
aPL-Positive Patients
Pregnant women with positive aPLs (but who do not meet criteria for obstetric or thrombotic antiphospholipid syndrome) should be treated with daily prophylactic aspirin; however, these women are advised against the combined use of aspirin and prophylactic-dose heparin as well as prophylactic hydroxychloroquine treatments.
In women who meet the criteria for obstetric antiphospholipid syndrome, the ACR strongly recommends a combined low-dose aspirin and prophylactic-dose heparin. Furthermore, these patients should be treated with prophylactic-dose anticoagulation for 6 to 12 weeks postpartum.
In women who meet the criteria for thrombotic antiphospholipid syndrome, a regimen of low-dose aspirin and therapeutic-dose heparin is strongly recommended throughout pregnancy and postpartum.
The ACR recommends against treatment with intravenous immunoglobulin or increased low-molecular-weight heparin doses. The panel also recommends against the addition of prednisone to a low-dose aspirin/prophylactic-dose heparin combination; however, the addition of hydroxychloroquine therapy to low-dose aspirin/prophylactic-dose heparin is conditionally recommended.
Anti-Ro/SSA or Anti-La/SSB Antibodies
Serial fetal echocardiography is recommended in pregnant women with anti-Ro/SSA or anti-La/SSB antibodies and should be performed starting between 16 and 18 weeks and continue through week 26. In women with a history of having an infant with complete heart block or neonatal lupus erythematosus, fetal echocardiography is recommended weekly during this time period.
If fetal first- or second-degree heart block is shown on echocardiography, daily treatment with oral dexamethasone (4 mg) is recommended; however, if a complete heart block without cardiac inflammation is shown on echocardiography, then the panel recommends against dexamethasone treatment.
All women who are positive for anti-Ro/SSA or anti-La/SSB antibodies should be treated with hydroxychloroquine during pregnancy, as hydroxychloroquine is associated with lowering risk for the fetus developing complete heart block.
Recommendations for Medication Use
Paternal Medication Use
In men with RMD planning to father a pregnancy, the panel recommends against the use of cyclophosphamide and thalidomide before attempting conception; however, continuation of hydroxychloroquine, azathioprine, 6-mercaptopurine, colchicine, and tumor necrosis factor (TNF) inhibitors are strongly recommended.
Continuation of methotrexate, mycophenolate mofetil, leflunomide, sulfasalazine, calcineurin inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs) is conditionally recommended on the basis of limited evidence, as is the use of anakinra and rituximab.
Maternal Medication Use
The ACR recommends discussing medication use in women with RMD well before attempting conception as standard good practice. The panel further suggests discussing pregnancy plans before initiating treatment with medications that affect gonadal function.
Discontinuation of methotrexate, mycophenolate mofetil, and thalidomide is strongly recommended within 3 months before attempting conception, as these medications are known teratogens, or agents that disrupt fetal development. Cholestyramine washout is recommended for women treated with leflunomide before pregnancy or as soon as pregnancy is confirmed, as detectable serum levels of metabolite risk pregnancy loss and birth defects. If life-threatening conditions occur in the second or third trimester, the panel recommends treatment with cyclophosphamide.
An observation period without medication or transition to pregnancy-compatible medication is recommended to ensure disease stability. In women with exposure to teratogenic medications during or shortly before pregnancy, the panel recommends immediate referral to the appropriate specialist or genetic counselor.
Compatible pregnancy medications commonly recommended for use in patients with RMD include hydroxychloroquine, azathioprine/6-mercaptopurine, colchicine, and sulfasalazine. Calcineurin inhibitors (tacrolimus and cyclosporine) and NSAIDs are also considered compatible with pregnancy; nonselective NSAIDs are recommended over cyclooxygenase 2-specific inhibitors during the first 2 trimesters.
If the patient is having difficulty conceiving, the panel recommends discontinuing use of NSAIDs because of the possibility of NSAID-induced unruptured follicle syndrome. NSAID use should also be discontinued in the third semester to avoid risk for premature closure of the ductus arteriosus.
If indicated, the ACR recommends continuing low-dose glucocorticoid treatments (10 mg daily of prednisone or nonfluorinated equivalent) during pregnancy. Higher doses of nonfluorinated glucocorticoids should be tapered, and a pregnancy-compatible glucocorticoid-sparing agent should be added if necessary. Administration of stress-dose glucocorticoids during vaginal delivery is not recommended; however, such treatment may be indicated during cesarean delivery.
TNF inhibitor therapy with infliximab, etanercept, adalimumab, or golimumab may be continued before and during pregnancy, as these therapies have minimal placental transfer and fetal exposure. Similarly, continuation of certolizumab therapy is strongly recommended.
The panel recommends women continue treatment with anakinra, belimumab, abatacept, tocilizumab, secukinumab, and ustekinumab while attempting conception but should discontinue use once pregnancy is confirmed. Women may continue rituximab treatment while trying to conceive and if life-threatening or organ-threatening maternal disease warrant use during pregnancy.
Medication Use During Breastfeeding
Women with RMD are encouraged to breastfeed if they desire and are able to do so, and the ACR recommends lactation-compatible medications in order to control disease. Hydroxychloroquine, sulfasalazine, rituximab, and TNF inhibitors are strongly recommended as compatible with breastfeeding. A prednisone daily dose <20 mg is also compatible with breastfeeding; however, women who use prednisone doses 20 mg are recommended to delay breastfeeding or discard breast milk accumulated in 4 hours after administration.
Treatment with azathioprine/6-mercaptopurine, calcineurin inhibitors, NSAIDS, and non-TNF inhibitor biologics (anakinra, rituximab, belimumab, abatacept, tocilizumab, secukinumab, and ustekinumab) is conditionally recommended during breastfeeding.
The panel recommends against the use of cyclophosphamide, leflunomide, mycophenolate mofetil, thalidomide, and methotrexate while breastfeeding.
Disclosure: Several study authors declared affiliations with the pharmaceutical industry. Please see the original reference for a full list of authors disclosures.
Reference
Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases [published online February 23, 2020]. Arthritis Rheumatol. doi:10.1002/art.41191
Read the original here:
ACR Recommendations for Managing Reproductive Health in Rheumatic and Musculoskeletal Diseases - Rheumatology Advisor
Posted in Testosterone
Comments Off on ACR Recommendations for Managing Reproductive Health in Rheumatic and Musculoskeletal Diseases – Rheumatology Advisor
Everyone Else Is Dealing with COVID-19. Idahos Pushing an Anti-Trans Bill – VICE
Posted: March 26, 2020 at 4:44 am
Lindsay Hecox was looking forward to finally running track in college. Hecox, a 19-year-old freshman at Boise State University, ran cross country in high school and said it was the only place where she felt like she could be herself. In addition to describing herself as a shy introvert, Hecox has attention deficit hyperactivity disorder, which made it difficult to make friends. Running provided her a shared experience to bond with her classmates.
Even though I definitely wasn't the most social, I still felt accepted, Hecox told VICE. I was a pretty good runner and everyone likes you if youre nice and you can run fast.
Hecox, who came out as transgender at the end of her senior year of high school, took the year off from running competitively to start transitioning and focus on her studies. Guidelines established by the NCAA state that trans female athletes must take medications that suppress their testosterone levels for a year before they are allowed to compete, and she started hormone replacement therapy last September. That means she could have been eligible for the 2020-2021 school year. (The NCAA told The Hill last month that it was monitoring the bills progress.)
If she had made the team, Hecox would have made history: No transgender student athlete has ever competed openly on a collegiate track team in Idaho. Hecox said she wasnt looking to break records, though. She just wanted to feel at home again.
Running really helps stabilize me, as I sometimes have mood fluctuations, Hecox said. If I go out for a run, it cleans the slate, and I feel like I can release a little bit of stress after that. If you have a friend and youre running alongside them, it feels like youre losing track of time and it gets your mind off things, as you just look forward to the next mile marker.
But Hecox could soon be banned from the sport she loves if Idaho signs a bill into law that would prohibit transgender women and girls from participating in school athletics in alignment with their gender identity. House Bill 500, also known as the Fairness in Womens Sports Act, applies to student-athletes playing in K-12 sports and at the collegiate level, no matter if the university is public or private. The legislation is headed to Gov. Brad Littles desk after passing the Idaho Senate last Monday by a 24-11 vote and the House last month, both of which are dominated by Republicans.
HB 500 isnt the only anti-trans bill awaiting the governors proverbial pen. Just days after the Senate overwhelmingly approved the trans sports ban, it also passed House Bill 509, which prevents transgender people from updating their birth certificates to match their lived gender. In a Thursday vote, all but six Senators approved the legislation, also called the Idaho Vital Statistics Act.
Little has yet to state whether he intends to support either of the two proposals, but when asked about them last month, the governor was quoted in the Idaho Press as saying hes not a big discrimination guy.
The bills have been met with virulent opposition from civil rights groups. Kathy Griesmyer, policy director for the American Civil Liberties Union of Idaho, said their passage would set a really dangerous precedent that would likely be used as a model for discriminating against transgender people in other states. Although the ACLU estimated that 17 states in the U.S. have introduced bills in the 2020 legislative session that would restrict the ability of trans students to compete in school sports, none have passed. HB 500 would be the first bill of its kind in the nation.
There are really devastating consequences if HB 500 becomes law, Griesmyer told VICE. This has the potential to harm intersex people, women who present too masculine, or anybody who wants to use this law to go after a competitor.
Among the most glaring issues with HB 500 is that it stipulates that a student athletes biological sex would have to be determined by one of three factors before they are allowed to compete. These options are a test of the individuals internal and external reproductive anatomy, normal endogenously produced levels of testosterone, or genetic makeup.
But as in the case of a similar bill introduced in Arizona, the legislation does not establish a process for bringing about these claims, meaning that any student or their parent could accuse an athlete on an opposing team of being transgender. Accused students, many of whom as likely to be cisgender, would thereby be forced to undergo costly DNA testing or an invasive genital exam. The proposal also does not state what body would be responsible for looking into complaints or how a students private medical information would be protected.
Notably, the Arizona bill was watered down to remove the genital testing components following public backlash. The Idaho legislation has remained unchanged, despite the concerns of LGBTQ advocacy groups.
This bill is not based on science, Kate Oakley, senior counsel for the Human Rights Campaign, told VICE. It is legislation that is based purely in misinformation about trans youth, and it is targeting trans youth for discriminatory treatment. For any trans person in Idaho, they are now on notice that their government is willing to make laws that are based on fear and not facts.
The anti-trans bills are likely to be met with immediate legal action should they be signed into law, as five former Idaho attorneys general argued in a March 17 letter addressed to Little. In particular, critics said HB 509, the birth certificate bill, would violate a court order from U.S. District Court Magistrate Judge Candy W. Dale, who ruled in March 2018 that Idahos policy of denying birth certificate corrections on the basis of gender identity was unconstitutional. Prior to that time, Idaho was one of three statesalong with Ohio and Tennesseethat did not allow trans people to update their birth records.
When that policy was overturned in district court, Emilie Jackson-Edney was one of the first people in Idaho to apply for a corrected birth certificate. Jackson-Edney, who sits on the board of the Pride Foundation in Boise, said she had started her application process eight years earlier but that the long wait was worth it.
Its necessary to navigate safely through society with minimal harassment and minimal scrutiny, Jackson-Edney told VICE, noting that a third of trans people without a corrected birth certificate report experiencing mistreatment and even physical violence as a result. Its a safety issue. For trans people having concurrent identity documents that reflect their gender identity is really critical, and not being able to have them would be very difficult.
What makes these bills particularly hurtful for trans people in Idaho is the timing of the legislation. They were pushed through the state Senate during the same week that municipalities across the country took measures to curb the spread of coronavirus, also known as COVID-19. And yet in Idaho, little has been done to stop its citizens from contracting coronavirus.
I havent seen one thing from the [state] government other than telling us to wash our hands, and I honestly don't think that were taking it very seriously, said Yarit Rodriguez, who runs a support group for trans youth in Idaho, told VICE. He added that it doesn't make sense to him why passing anti-trans bills is more important than an outbreak affecting multiple communities.
The lack of statewide action on coronavirus is particularly personal for Hecox, who was being forced out of her dorm at Boise State as she spoke over the phone on Thursday. The university sent an email to students earlier the same day ordering anyone who hadnt already abandoned campus housing to evacuate the premises within the week. Although many students who have family in the area have the option to simply move back home, it wasnt so easy for her.
I was living with my grandparents in California before, she said. They don't want another person living with them because of their age. They are susceptible to having a bad reaction to the virus or dying.
To keep Hecox from being homeless, her mother is uprooting her life in California to move to Boise. Even as the federal government debates a trillion-dollar stimulus package that would provide greater assistance to families like hers, which have been forced into impossible situations, Hecox noted that Idaho lawmakers had yet to make any similar moves. The Senate wrapped for the year on Thursday, while the House finished up the following day.
They have not passed any legislation for that, she said of a statewide coronavirus relief effort. They dont have their priorities straight.
Sign up for our newsletter to get the best of VICE delivered to your inbox daily.
Read the rest here:
Everyone Else Is Dealing with COVID-19. Idahos Pushing an Anti-Trans Bill - VICE
Posted in Testosterone
Comments Off on Everyone Else Is Dealing with COVID-19. Idahos Pushing an Anti-Trans Bill – VICE
The Complete Guide to T Replacement | T Nation
Posted: March 24, 2020 at 8:49 pm
So you just got the results of your blood test and your testosterone charts out at 600 nanograms per deciliter (ng/dl) of blood. You know that "normal" is somewhere between the range of 200 and 1100 ng/dl. So you breathe a sigh of relief and mentally give your balls a slap on their backs for a job well done in kicking out a reading of 600. But what does that number really mean?
Unfortunately, that reading of 600 ng/dl means almost nothing. Testing for testosterone is rife with inconsistencies. Blood values of testosterone vary by the minute and the day. The only way to get a reasonably accurate reading would be to collect urine over a 24-hour period and have the lab use it to measure testosterone and its metabolites. Alternately, you could donate at least three blood samples from different times during the day. The lab would then pool the samples together and test that sample.
But nobody does it that way. It's more expensive, more time consuming, and more inconvenient. Besides, the doctor would think you were nuts for even suggesting it because, really, who are you to question him, you hapless mortal, and why are you worried so much about your T levels? You should be content with vague blood readings, average testosterone levels, and at least quasi-functional balls like the rest of the sheep on the planet.
And even if you did pool multiple blood samples, it still wouldn't tell you much. For one thing, even though the results might indicate that you have a normal level of testosterone, it might not be normal for YOU.
Maybe you would've measured a high octane 1100 when you were in your twenties, but now you're sputtering along at a comparatively low octane 600 and spend your days Facebooking, or it's offline equivalent, scrap booking. The only way you'd know what was normal for you is if you'd established a testosterone baseline reading before you turned 30. But again, nobody does that.
Then there's the issue of steroid hormone binding globulin, or SHBG. It's a glycoprotein that literally binds up the sex hormones, including, on average, about 60% of your testosterone, and that percentage keeps climbing as you grow older.
The more SHBG you have, the more of your testosterone is bound up, leaving less of it free to do all the good stuff. So while your testosterone level may be 600, a good portion of it is locked up. It can be maddening. It's like having a genie in a bottle that you can't uncork.
That's why, at the very least, when trying to determine your T levels, doctors should ask the lab for your total testosterone levels, your "free" testosterone levels, and your "bioavailable" testosterone levels so you can get a little bit better of an idea of what your situation is. But, you guessed it, nobody does that, at least very few conventionally trained doctors.
And we can't forget about estrogen, or more specifically, estradiol levels in men. Your testosterone levels may read normal, but if estradiol levels are high, it could thwart testosterone in its efforts to make you the man you're supposed to be.
As you can see, determining normal testosterone levels is a tricky beast. So, regardless of what your lab values are, and given the problematical nature of the lab tests, you have to instead rely on symptoms and the simple desire to be more than you are, hormonally speaking.
Do you have less energy? Have you experienced an inexplicable increase in body fat and have trouble losing it? How about a loss of muscle tone and an inability to make progress in your workouts? Does your erection sometimes falter and wane? Do you think more about your lawn than lady parts?
How about premature aging? Difficulty in concentration or memory? Depression? Or maybe a lack of "appropriate aggressiveness" where you don't take the initiative in matters of business or the heart?
Maybe you're nervous, or always pissed off, ready to tear the head off the pudknocker in line in front of you who bought the last damn cinnamon roll? Any of these things could be indicative of low T, including, seemingly paradoxically, that last item on the list about undue anger levels.
Historically, low testosterone, or hypogonadism, has largely been a problem of middle age and beyond. A 2006 study reported that 39% of men over 45 suffer from it. Another study said that while 13 million men in the U.S. may be deficient in testosterone, fewer than 10% get treatment for it.
That's quite a chunk of human change, but consider that these statistics reflect only those men that were clinically deficient, i.e., their lab tests indicated they were low. It leaves out the millions many who are young or relatively young whose lab tests say they may be fine but based on their symptoms, are probably deficient.
It also ignores the younger men who don't typically get their T levels tested. Millions of them are likely deficient, too. Not because of old age, but because of environmental estrogens, pituitary and testicle stifling chemicals in general, and probably even a soft, cushy, modern, convenience-filled low-testosterone lifestyle.
In fact, it's speculated that the testosterone levels of today's average man are roughly half of what his grandfather's were, at a comparative point in life.
Your first task is to find a progressive doctor, or at least one who isn't threatened by a patient who knows what he wants. Luckily, there are now plenty of low-testosterone treatment centers around the country. Unfortunately, many of them are in it for quick dough and they aren't likely to be as informed on the topic as you'd like them to be. All the more reason for you to take charge.
Once you find the right doc, describe your symptoms, confess your desire to get testosterone replacement therapy, and ask for lab work. But make sure you get tests done in exactly the way specified below. (For instance, if you don't ask for a "sensitive assay" estradiol test for males, they're going to measure your estradiol the same as if you were a ballerina from the Bolshoi ballet suffering from menstruation problems.)
Ask for this lab work:
These tests will give a fairly good baseline reading of where you stand so that when you have follow-up blood testing done three to six months later, you can see if you're on the right dosage and whether you're suffering any insidious negative side effects.
If you test out as deficient in testosterone, or if you have symptoms of low testosterone, you likely want to do something about it. There are definitely over-the-counter supplements designed for this very purpose. (Alpha Male and Tribex are the most potent.) And while effective, they're best used by healthy younger men who want a boost in T levels for bodybuilding purposes. They probably aren't the best choice for men who are clinically low and who've made the choice to undergo what's usually a lifetime commitment to testosterone replacement therapy, or TRT.
Testosterone injections are the creme de la creme of TRT. While it's true that testosterone gels (see below) create a more natural ebb and flow of testosterone, injections, provided they're administered properly, give you the most muscle-building, libido boosting, rock-your-world bang for the buck.
You essentially have two injectable choices in America, testosterone enanthate and testosterone cypionate. The half lives of these esters differ slightly, but it's not that big a deal, especially if your dosing is adequate and you've chosen a suitable injection method and schedule.
For most men, 100 mg. a week of either ester is enough for effective TRT. However, some men need less and some men need more, possibly up to 200 mg. a week. Beyond that amount and you're pretty much on a mild bodybuilding steroid cycle instead of testosterone replacement.
Even if you're injecting weekly (always on the same day), you still might suffer a bit of a low-testosterone lull as you get further away from injection day. To remedy this, many men split their dosage in half and inject twice a week instead of once a week. Doing so keeps your blood levels of testosterone fairly stable.
And while many men micromanage their hardest workouts to coincide with the peaks and troughs of their TRT, it's largely an unnecessary battle, especially when you're giving yourself two injections a week. Injections given that close together ensure that you're pretty much always riding a peak.
Additionally, you might want to consider subcutaneous injections rather than intramuscular injections. Dr. John Crisler, noted testosterone guru, insists that sub-q is much more effective, so much so that 80 mg. of testosterone injected under the skin is equal to 100 mg. injected intramuscularly. Plus, he adds, you don't poke your muscle bellies full of thousands of holes over the course of a lifetime of TRT.
All you do is take a pinch of skin on your glute, thigh, or even belly, and inject a tiny needle into the fold at either a 45-degree or 90-degree angle. Fully depress the plunger, release the skin, and you're good to go. Whether Crisler is right about the potency of sub-q injections isn't known for sure, but it has the ring of truth and it's worth a try.
As mentioned above, testosterone gels provide a much more natural androgen rhythm and there's probably some argument to be made that mimicking the body's natural rhythms is the way to go. However, many believe it doesn't have the same bang for the testosterone buck as injectable esters.
Besides, gels have their drawbacks. You should only apply gels to freshly showered skin. You should refrain from swimming or working up a sweat for at least an hour. Furthermore, you can't, under any circumstances, let a child or female (especially a pregnant one) come into contact with the treated area until it's absolutely dry.
If you do decide to use gels, you must apply them once (or in some cases, twice) a day. Don't use your hands to apply the gel, though. Any gel on the hands doesn't soak in to the bloodstream. It's like applying gel onto an old catcher's mitt, which isn't very permeable. Instead, squeeze the gel onto your forearms and rub them together. That way you won't waste any.
Just about everything else, including creams, pellets, and sublingual drops, isn't much worth discussing. Granted, creams can be effective, but they're messy and they don't penetrate the skin as well as gels. Pellets and drops, however, are either ineffective or impractical and make accurate dosing all but impossible.
There are, however, other protocols that have proven to be effective in treating secondary hypogonadism (where the hypothalamus, for whatever reason, isn't telling the pituitary to produce LH and FSH, which in turn cause the testicles to produce T), like selective estrogen receptor modulators, or SERMs.
Two of the most commonly known ones are Clomid (clomiphene) and Nolvadex (tamoxifen). They simply trick the pituitary into producing LH, which then tells the testicles to get to work. Exact protocols are beyond the scope of this article, though.
One of the big fears about undertaking TRT is infertility and shrinking balls. While TRT does reduce the number of sperm that a man produces, it'd be foolish to think that your replacement dosage has rendered you safe from becoming a daddy. In many cases, though, the testicles will shrink and sperm count will drop, but these effects are easily prevented by concurrently administering human chorionic gonadotropin, or HCG.
The drug mimics LH so that your testicles don't shut down. They'll still produce sperm and they'll still produce testosterone, so shrinkage won't occur. Additionally, there are LH receptors throughout the body, and HCG attaches to these system-wide receptors. Anecdotally, at least, this causes men on TRT and HCG therapy to report feeling pretty damn good.
HCG is administered subcutaneously via an insulin needle and it's easily available to your doctor through various compounding pharmacies around the country. The generally recommended starting dose is about 100 iu a day, working up to higher daily doses or, alternately, 250 or 500 administered twice a week.
There are a small number of bad things that can happen when on TRT. One is only an issue if you have prostate cancer before starting TRT therapy.
Note that there's absolutely no evidence even after researchers have compiled thousands of studies and patient histories that TRT can cause prostate cancer. However, for some reasons that we don't totally understand yet, TRT can make prostate cancer worse. That's why it's important to have digital rectal exams (DREs) every year while continuing to monitor prostate specific antigens (PSA).
TRT can also cause a condition called polycythemia, which simply means that the testosterone therapy has caused your body to produce too many red blood cells. Instead of freely flowing through your veins, your blood gets thick and spurts along like the stuff that comes out of the Dairy Queen soft serve machine and it can understandably cause heart attacks and strokes when it clogs up your plumbing.
That's why it's important to monitor both hemoglobin and hematocrit. If hemoglobin exceeds 18.0, or hematocrit exceeds approximately 50.0, you either need to adjust your dosage of testosterone, donate some blood to the Red Cross, or submit yourself for what's called therapeutic phlebotomy (a simple blood draw in a doctor's office).
The much-dreaded gynecomastia is almost unheard of in males receiving TRT. Gynecomastia, or the growth of male breast tissue, is seen almost exclusively in men taking pro-bodybuilder levels of testosterone (1,000 to 3,000 mg. a week) or testosterone analogs. Hair loss is a possibility, but it seems to stabilize in your 30's. If you've made it that far without losing your hair, it's highly doubtful that TRT will make things any worse.
All of the rest of the stuff you may have heard about testosterone causing heart attacks or anything else bad is horribly, horribly wrong. If anything, men with low testosterone levels are much more prone to a host of maladies, including heart disease, diabetes, dementia, and pretty much everything else usually associated with old age, death, or decrepitude in males.
Testosterone does cool stuff to the body, but it usually doesn't happen overnight. While you might start feeling pretty good, almost elated, after starting therapy, the various physiological benefits take varying amounts of time.
See the original post:
The Complete Guide to T Replacement | T Nation
Posted in Testosterone
Comments Off on The Complete Guide to T Replacement | T Nation
The Most Common Causes Of Hair Loss In Women And How To Treat Them – HuffPost
Posted: March 20, 2020 at 4:48 pm
Hair often plays a critical role in forming a womans identity, so it should come as no surprise that female hair loss can have a major effect on self esteem, mood and confidence. It can even result in increased stress, anxiety and clinical depression, according to board certified dermatologist Anna Drosou of DermSurgery Associates in Houston, Texas.
Discussion around female hair loss pales in comparison to talk about male baldness, so we spoke with several experts who explained to us the most common causes of female hair loss and how to treat them.
As always, consult with your doctor before diagnosing yourself with any of the following causes or conditions.
First, Get To Understand Your Hair Cycle
Everyones healthy hair cycle follows a similar pattern: The active growth phase of hair (anagen) lasts 3-5 years, followed by a 10-day transitional period (catagen), and finally the telogen phase, in which the hair sheds and follicles fall out. The follicle is then inactive for three months before the whole cycle is repeated.
Some people experience hair loss at a pace thats more rapid than usual (telogen effluvium), which is a prolonged (and usually sudden) period of hair loss. Telogen effluvium is a reactive type of hair loss, caused by some sort of internal disruption, i.e. nutritional inadequacies, illness, surgery or hypo/hyperthyroid, Anabel Kingsley, a trichologist, associate member of The Institute of Trichologists and brand president at Philip Kingsley, told HuffPost.
SCIENCE PHOTO LIBRARY via Getty Images
Hair loss, thinning and similar issues occur when the normal hair cycle is disrupted, Kingsley explained. This can be due to a variety of reasons, some common for both women and men, others focused specifically on women. The American Academy of Dermatology defines normal hair loss as 50 to 100 strands a day, so anything more than your usual amount could be reason to see a doctor.
Drosou said that hair loss due to hormones, stress, iron and diet-related causes is generally reversible. Its harder to reverse hair loss connected with hereditary causes or rare inflammatory cases. Upon first seeing a patient, Kingsley first conducts blood tests to look at potential hormonal or nutritional deficiencies.
Hormones
Hormones can wreak havoc on our skin, and unfortunately that applies to our hair, too.
A balance of estrogen, progesterone and testosterone is necessary for healthy hair growth, according to Roy Stoller, a board certified surgeon and founder of Hair Transplant NYC.
Although estrogen usually promotes hair growth, when in excess, it can tip the balance and actually increase testosterone, causing a testosterone-related hair loss, Stoller told to HuffPost. In that case, there may be a genetic predisposition to dihydrotestosterone (DHT), which attacks the hair follicle, diminishing and eventually resulting in total loss of the follicle.
Stoller provides a solution to this situation to block the conversion of testosterone to DHT and prolong the life of the hair follicle: The one most prescribed drug is Finasteride. Although only approved for men, women have also had success with it. This is a prescription-only drug, so speak to your doctor if you think it might be a good fit and ensure you know all the contra-indications, which include loss of libido among others.
Pregnancy Hormones
Its not uncommon for a pregnant woman to receive compliments on her hair, which appears fuller, shinier and overall more healthy during pregnancy. Though not every woman experiences this, for those who do its due to a prolonged anagen phase thanks to higher estrogen and progesterone hormones during pregnancy.
However, Stoller noted that 40% of women will experience excessive shedding (telogen effluvium) post-birth. This is due to the physical stress of the labor, and its self-resolving without treatment, Drosou said. Stoller added the effects are temporary, lasting around three to four months, and starting at three months post-birth. Being diligent with the intake of all necessary vitamins and minerals is helpful in dealing with this type of hair loss, and its completely reversible.
Menopause Hormones
Both before and during menopause, hormonal changes affect hair growth, particularly due to a decrease in estrogen and progesterone. Stoller said that female pattern hair loss is more common during that period, and could even relate to hair loss from androgens (male hormones) depending on the womans genetics. The decrease in the female hormones leave the hair cells unprotected from circulating androgens. Over time, the hair shafts will thin, miniaturize and eventually die, Stoller said.
Estrogens are hair friendly and help to keep strands in their growth phase, Kingsley explained. They also offer a sort of buffer against androgens, which are not very good for your scalp hair. The extent to which a woman will experience changes to hair diameter is down to genes, she added.
Studies have shown that Finasteride can be successful against hair loss in pre- and post-menopausal women who do not intend to be pregnant. There are suggestions that anti-androgen hormones can help, as well as iron supplements. Hormone Replacement Therapy (HRT) can be beneficial in hair loss too, by slowing it down or stopping it completely, studies show. Another topical treatment that is proven to work in menopausal women is Minoxidil.
Thyroid Irregularities
The thyroid gland is responsible for regulating our metabolism, and its usually the first thing a doctor will look at if you have issues with weight changes or hair loss.
Thyroid hormones are released in the body at a steady steam, Stoller said, regulating everything from breathing to temperature, body weight and hair growth. Nutrition and thyroid disease can affect the release of those hormones, and Drosou notes that low thyroid hormones, also known as hypothyroidism, can cause reversible alopecia and even lateral eyebrow thinning. With proper medication to support the thyroid, the hair loss can be completely reversed.
Anemia
Anemia, or iron deficiency, is one of the most common causes of hair loss in women, apart from hormones.
Low iron stores can force hair into a chronic rest phase, resulting in increased shedding and reduced density, Stoller said. Drosou adds that iron deficiency is quite common if youve experienced sudden weight loss, and is often the result of going on a vegan diet.
Iron is used both for hair production and red blood cell production, Drosou said. The body wisely prioritizes the red blood cell production, so if it has a limited amount of iron intake, the first thing to be affected is the hair. Speak to your doctor, who will be able to give you a suitable iron/ferritin supplement depending on your needs.
Eating Disorders
These affect the body in various ways, creating physical stress for the body and often resulting in hair loss.
Stoller notes that the protein in hair (keratin) is not essential for the body, and at periods of malnourishment, hair growth will stop. The body prioritizes nutrients going to vital organs (brain, heart, lungs) over hair, so shedding occurs, Stoller said. Depending on a persons age, genetic makeup and health status, regular hair growth usually returns in about six months after the malnourished state is resolved, Stoller said.
Heredity
The hereditary form of alopecia is female pattern hair loss, or androgenetic alopecia, Drosou said. This is usually seen as diffused thinning, not bald spots.
She notes that this form of hair loss can happen at any point during adult life, and is more common in connection to menopause as its connected with androgen levels. Women with conditions like polycystic ovary syndrome, which is connected with androgen levels, could see hair thinning earlier.
Pongsak Tawansaeng / EyeEm via Getty Images
Medications that block androgens, like spironolactone, are somewhat effective at reducing hair loss and preventing worsening of the condition, Drosou said.
Frontal Fibrosing Alopecia
This is a type of hair loss that leaves scars at the front of a womans hairline, and its becoming more common, particularly in post-menopausal women. Kingsley said its now seen even in younger women, but the exact triggers arent known.
It is thought to be caused by a faulty immune response, whereby your body attacks and destroys hair follicles at the front of your hairline, leaving scar tissue behind, Kingsley said. Unfortunately, you cannot regrow hair from a scarring alopecia. However, at [hair] clinics we endeavor to stop it from progressing and reoccurring.
This is not to be confused with traction alopecia, a type of hair loss thats a result of wearing tight hairstyles, like ponytails or tight braids worn repeatedly that pull out the hair follicles. Kingsley said these hair styles should be avoided as they can cause traction breakage, which could pull out hairs from the follicle and then lead to traction alopecia over time. If treated early, the hair can grow back normally after six months. Otherwise, it could cause non-reversible scarring alopecia, which is often seen in women who use weaves, hair extensions, braids and chemical relaxation.
Insulin Imbalance
Insulin is a hormone that regulates energy. Its obtained from the food we eat, and then released into the body to help store energy for future use. Since insulin can affect hair growth, its important to take note of the glycemic index (GI) a ranking of how foods affect your blood glucose levels of foods you eat.
Eating high-glycemic foods in excess, often in combination with a sedentary lifestyle, can cause an overload of insulin in the body, Stoller said. Too much insulin disrupts ovulation and signals the ovaries to make more testosterone, Stoller said. A change in diet and lifestyle can help insulin levels and restore hair growth.
Stress
We know stress can be catastrophic for the body and the mind, so its no surprise that stress plays a major role when it comes to hair loss.
Kingsley notes that anything that affects your physical well-being impacts your hair to an even greater degree. Hair is non-essential to physical survival and so it will always be the first part of you to suffer when something is off-kilter, he said.
Stress is connected to our cortisol levels, which are increased, Stoller said, when insulin levels rise, in turn triggering a testosterone increase. After a particularly stressful event, and 2-4 months after the event, women may experience hair loss, but after 6-plus months hair returns to normal, Stoller added.
Drosou notes that stress-related hair loss is also seen after events like childbirth, hospitalization, divorce and the death of a significant other. The reason is that stress induces a larger percentage of follicles to enter the telogen phase, resulting in increased shedding of hair. The hair follicles remain intact, so complete recovery is expected after 6-12 months, Drosou said.
The Takeaway
No matter what the underlying cause of hair loss might be, as with many health issues, a balanced diet with the necessary nutrients and vitamins is essential.
Hair is the first point of damage when something is out of balance in our bodies, as its a non-essential tissue or a vital organ. But as hair cells are the second-fastest growing cells our body makes (the fastest-growing are the cells lining the gastrointestinal tract), their nutritional requirements are high, Kingsley said. Supplements can be helpful in the support of good hair health, in conjunction with a healthy balanced diet. Looking after the scalp and cleaning it properly is also important to support healthy hair growth, as well.
As soon as you notice an increase in hair loss, its important to take action and see a dermatologist, trichologist or specialist. Every situation is very different, so seeing an expert is essential.
Excerpt from:
The Most Common Causes Of Hair Loss In Women And How To Treat Them - HuffPost
Posted in Testosterone
Comments Off on The Most Common Causes Of Hair Loss In Women And How To Treat Them – HuffPost
Dr. Drew is worried about the "impact of pornography" and reveals his COVID-19 fears – Salon
Posted: March 20, 2020 at 4:48 pm
Dr. Drew Pinsky stopped by"Salon Talks" recently to talk about a new thriller called "Final Kill," in which he plays a therapist. Many will know Pinsky from his nationally syndicated radio show "Loveline," which ran from 1984 to 2016, and his many TV shows focusing on sex and addiction, as well as reality shows like "Teen Mom" and "Celebrity Rehab."He also hosts the advice-driven podcasts,"Dr. Drew After Dark" and "The Adam and Dr. Drew Show."
"Medicine saved my life, quite literally," he told me. "I woke up every day of my training thinking, 'I love doing this,'feeling like it was so important what I was doing." Pinskybegan his radio career as a medical student during the AIDS epidemic of the1980s. "No one was talking about it, particularly not to young people," he remembers. "That's what motivated me to get on the air. I thought I was doing community service for the first 10 years of going on the radio."
The desire to help people led Pinsky to get additional degrees. He originally trained as aninternal medicine doctor, then later moonlighted at a psychiatric hospital and became a specialist in addiction. "I have noticed that I start to gravitate towards the big problem of the time," Pinsky said. "Right now, to me, it's homelessness. I'm deeply involved in big problems. Childhood trauma has been a massive issue for the last 30 years, so I got involved in that, and then drugs and alcohol became the problem, so I spent 20 years running a drug and alcohol treatment center."
Calling Los Angelesan "open-air asylum" for homeless people, within which diseases can spread rapidly, Pinsky expressed concerns about transmission of COVID-19, in a way no pandemic has been in many years. Pinsky alsosays he is working on a new book directed at young people, which he hopes will address a key important issue in sex and relationships.
To hear more from Pinskyon playing a real and pretend doctor on TV, and why he thinks millennials reject addiction treatment methods that have worked for previous generations, watch my "Salon Talks" episode with Dr. Drew here, or read a Q&A of our conversation below.
The following transcript has been lightly edited for clarity and length.
Is true that you love to sing opera or did at one time?
I did. Some people will know I was on "The Masked Singer" a couple months ago.
How'd that go?
Not so great. It turns out that in the intervening year,I've lost a little bit and I have all kinds of problems with my vocal cords, but I got through that show, which was the goal.
What happened? Polyps?
A hemorrhage andreflux and all kinds of good stuff. They wanted to do a bunch of laser, which I don't have time to do because I spend my life talking. The way I got the hemorrhage is I knew I was about to do that show. I thought, I better to do some singing. So I was down both at Stonewall and The Monster in the Village, and I started, I really pushed it. And also, my mid-range was gone. I thought, oh Jesus, something's wrong. It was.
But did they love it at Stonewall Inn? That's the famous gay club here in New York.
Yeah, and The Monster is another great gay club that has a pianist there. Onthe weekends, they do a lot of cabaret, karaoke stuff.
What is your favorite thing to sing?
Musical stuff. It's so easy for me, and you don't want to hear this whole story, but when I got into "The Masked Singer" I put the costume on and all of a sudden I realize it's a rock eagle. I have to sing rock songs, and had to change everything. It was a big mess and I got through it. Then I got kicked off so it's fine.
You're glad that you stayed in medicine?
Yes. Medicine saved my life quite literally. I mean I woke up every day in my training thinking, oh God, I love doing this. I felt like it was so important what I was doing and I was deep in the AIDS epidemic back in the '80s, and that's what got me on radio. I wanted to talk about it, and I realized no one was talking to it, particularly not to young people about it. I was like, are you kidding? We've got to talk about this. That's what motivated me to get on the air. I thought I was doing community service for the first 10 years I was doing it. It was a one night a week thing. I was talking about medical topics, a lot of HIV and safe sex talk back then, and suddenly became a huge part of my life.
It was a taboo topic at the time and people had so many misconceptions.
It was weird. Because yes, there were loads of misconceptions, but no one was talking to young people. Literally, I was 24 years old and I was thinking, oh my God, I know what 18- to 20-year-olds are up to, we got to tell them about this. That was considered outrageous. Why would you talk to them? They're not having sex. And I thought, oh my God, we've got a problem. I was there, I was elbows deep in it. And if you weren't there administering, you're not here now. You know what I mean? You forget how horrible that was. I get chills.It was the most tragic, saddest chapters. Wonderful people are lost. They're just not here to tell the story, so really the rest of us got to kind of tell it.
Do you have fun playing a therapist in films and on TV? What kind of allowances can you make there, as opposed to working with your real patients?
What people don't understand about reality shows we put together, that was real work. That was me and my team doing what we do, period. And how they put it together and edit it, and what you see is a little distorted because people would say things like where's the treatment? It's like, yeah, no kidding. It's just the drama is all you're seeing, okay, that happens in treatment. The reality shows we did, I just took my team and we just did the work. We always do.
On this movie ["Final Kill"], I find it interesting. It's kind of like Tony Soprano, right? I'm treating a criminal essentially, or maniac, and I'm trying to understand why he's so messed up. Why is he such a disturbed patient? That's an interesting challenge to put yourself in that spot and then try to imagine what that would be like. I enjoyed it.
Yes, tell us more about your role in "Final Kill."
Think Tony Soprano and his therapist. I'm trying to get him to take medication mostly. And then you find out as the viewer why he's so stressed out. He has a pretty, pretty violent life. Pretty violent, messed-up challenge ahead of him.
How many takes did you have to do to keep a straight face with Ed Morrone screaming in your face and being so crazy?
A bunch. And he was even supposed to be crazier in the script, and I said, look, if you got crazy like that, I would call law enforcement. That's what I would do in that situation. They were like, okay, we're changing it.
In one scene, the character Mickey has a long stretch where he berates therapists, including you, in saying that you're using people and giving them medication for all sorts of purposes, including one that he thinks makes him not perform as well in bed. In your real life treatment of patients, how much of your real advice about sex is based in talk therapy versus necessary medication?
Idon't do a lot of day in, day out sex treatment in my clinic work. On the radio, many, many years of helping with that area. It ends up being talk, but I'm gravely concerned about psychotropic medications and their effect on our sexual functioning. And they can affect any stage of the sexual arousal and detumescent cycle. Doctors don't pay enough [attention]. I'm worried about hormones and their effect on that too. I'm worried about lack of hormones. On some of my streaming shows and podcasts, I will focus on those issues because people need to be informed. The doctors don't have the time, and aren't spending the time to educate them. And when a woman is put on a hormonal contraceptive, they should be given a ton of education.
I can't tell you how often it's vaginal dryness and decreased libido and no orgasm function. It's from these high-dose progesterones. By the same token, we were kidding about peri-menopause, but women are treated for depression when they should be treated for hormonal imbalances, and they leave out testosterone always. That's sexist in my opinion, because that's the "male hormone" no, it's not. It's kind of a big topic for me, proper assessment and proper education, and time spent doing that, not available as medicine is practiced today.
That's probably the case in a lot of silos of medicine, right? There's too many patients, too much of a load.
Everything is funneled up to the doctors and we don't have time to do what we'd like to do, which is build a relationship and spend time educating you. That goes to paraprofessionals and physician extenders. That's sad. It really bothers me.
We're both parents. What kind of advice do you have on raising teens today?
The biggest problem right now is screens. I think within 20 years we will think of screens the way we think of tobacco now. Screens are the source of a lot of really serious distress for young people. It's bad enough dealing with it normally without the screens. But the screens have added a layer where it's 24/7, it's raining down on them all the time. There's no escaping whatever they're trying to escape. There's mistakes that we all make during adolescence that now exist forever. There are literally crimes they could commit unknowingly. In many states, just sexting or requesting a sext, both are felonies and can affect these kids the rest of their life. And there's just a whole layer to the experience that. I have friends that are therapists and mental health professionals that just focus in this area, and they only give their kids 30 minutes a day on the screen. I don't know how you do that. It's almost impossible.
All right, so you and Adam Corolla and "Loveline." I remember those early days on MTV, which of course evolved from radio and the awkward questions in calls. What madeyou want discuss sex and addiction on air?
I'm an internist by training. I do internal medicine and that's why I was doing AIDS patients. I was struggling with that epidemic. I was there when we brought out the first AZT, and I was in the middle of all that. Then I ended up moonlighting in a psychiatric hospital and got very involved dealing with psychiatric patients, both medically and through the addiction. And what I noticed is, is eyes start to gravitate towards whatever the big problem at the time is. Like right now, to me it's homelessness. I'm deeply involved in that problem. And at the time, it was HIV and AIDS. Then that translated to sex and relationships, trauma, childhood trauma has been a massive issue for the last 30 years.
I got involved in that and the treatment of trauma, then drugs and alcohol became the problem. And so I spent 20 years running a drug and alcohol treatment center. I finished that up, started thinking about other things. And now I've been involved with the homelessness epidemic. And this corona[virus]thing has been sort of a sidebar. And by the way, if the homeless start getting corona, in Los Angeles, we're going to have a big damn problem. It's an open-air asylum. These are open-air asylums with people rotting in our streets, dying three a day in LA County. If three a day were dying of corona, people would be running down the street with their hair on fire. Because they're homeless, dying three a day and drug addicted, everyone goes, oh well. This is unconscionable.
It sounds like you tend to focus your energy on where the problem is.
Yeah, that's where I tend to go and because I've had this crazy broad experience in medicine where I did general medicine and infectious diseases and then I did a whole lot with psychiatry and drug and alcohol, I have kind of a broad experience that young physicians don't have. They don't get that training. I'm trying to use as much of it, give as much of it back as I can.
This is one of my little policies since I got involved in media. I was like, these guys know how to create media that people listen to and I'm just going to inject myself into it. That's always been my policy. If you need to go somewhere crazy, you go, I'll try to make it meaningful at the end.
And inject the medicine.
Yeah, inject some of my message. "Teen Mom" is another model of that. When they came to me with "Teen Mom," I was like, this is going to work. This is going to affect teen pregnancy in this country. I know it. Whenever you have a dramatic story with a relatable source that helps young people, attracts young people's eyes and so they could see what happens if you make certain choices, my job is just to explicate and they'll get it.
How do you yourself mitigate stress?
I noticed early on in my work at a psychiatric hospital that certain personality types and addicts were having their way with me. They could really manipulate me and get me to do, respond in the middle of the night and try to help them and do all these crazy things that always ended up in catastrophes. So I went into therapy for a long time and it's just essential. Doing your own work is just a key part of being effective in all cases. You have to be able to just be present on behalf of the patient and not let your s**t get in the way of it.
How do you define yourself in the field? Years ago the New York Times called you Gen X's answer to Dr. Ruth, with an AIDS-era pro-safe sex message.
That was then. Now again, I have this broad medical and psychiatric experience, and I'm just trying to use the media to do good. That's it. I'm a medical professional with lots of extraordinary experience, and I'm trying to inject myself into the media in places where people are watching, to try to shape things. My naive little idea back in the beginning was, oh my God radio has been such a negative influence on people's sexual behaviors and drug and alcohol and they've been encouraging all this stuff. I wonder if I climbed into that vehicle, if I could move the battleship in a better direction. That kind of idea has been with me ever since, like just shaping the culture. I may not be able to get every case we're dealing with, but there'll be somebody listening and that will kind of move things in a healthier direction, which these days is hard, hard, hard, hard.
Do you get a sort of a sense of the zeitgeist, if you will, about what people, at least in the world of addiction and sexual challenges, are looking for these days, especially with the internet?
I'm very, very concerned about the impact of pornography. We don't even know what it's doing to our brain development and I'm concerned it's doing something. Obviously it does a lot of things to our attitudes and our feelings about men and women, and what's appropriate behaviors and whatnot. And the drug and alcohol issue is completely out of control right now. We have just been through this opiate crisis and we're mostly getting the prescription opiates under control, but fentanyl is still massively a problem. Meth, massively a problem.
A publication [coming out] in a few days that shows that mutual aid societies, free services, are as effective or more than professionally managed services when abstinence is your goal. More effective than professionally managed services, and it's free. That should not be under attack, ever. Now there's an evidence basis for it, and it's been under attack and people reject it, in particular young people reject it. That's been one of the challenges lately, is they just won't engage the way previous generations have.
Why do you think that is?
I don't know. We can't figure it out. None of us can figure it out. It's literally like, "Hey, that's not for me. It's not something I can relate to." And it has something to do with the spiritual piece. Like the idea is anathema to them. It's not the God thing so much as . . . millennials really don't perceive hierarchies.
They either don't perceive them or don't like them. And lot of these communities have hierarchies. They're old timers, or people that have long periods of time there. And you're supposed to look to them for guidance and help. Alot of the millennials are just like, I don't even know what you're talking about. That was just some old person.
We're talking about narcotics anonymous, NA?
Any of the 12-steps.
What about moderation therapy?
It doesn't work, but really what you're talking about is harm avoidance, right? If you got opioid addiction, or any addiction, we would not be doing moderation therapy, we'd be waiting for abstinence. But there are people for whom that is appropriate, and for whom nothing better is likely to work. Harm avoidance and replacement therapies of all kinds need to be used, but they need to be deployed appropriately. One of the problems in my field is, we don't know which cases to select for which treatments. There tends to be enthusiasm one way or the other rather than good science. And my thing is, I use replacement where we should be using it, use abstinence where we should be, and let the science direct us, and that's it.
Read the original here:
Dr. Drew is worried about the "impact of pornography" and reveals his COVID-19 fears - Salon
Posted in Testosterone
Comments Off on Dr. Drew is worried about the "impact of pornography" and reveals his COVID-19 fears – Salon